Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

Clinical trial NCT03340129 · RECRUITING

Trial details

NCT number: NCT03340129
Sponsor: Melanoma Institute Australia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage Iv

Start date: 2019-08-14
Primary completion: 2026-08-01
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.